"Vaccines, Subunit" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines consisting of one or more antigens that stimulate a strong immune response. They are purified from microorganisms or produced by recombinant DNA techniques, or they can be chemically synthesized peptides.
Descriptor ID |
D022223
|
MeSH Number(s) |
D20.215.894.860
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vaccines, Subunit".
Below are MeSH descriptors whose meaning is more specific than "Vaccines, Subunit".
This graph shows the total number of publications written about "Vaccines, Subunit" by people in this website by year, and whether "Vaccines, Subunit" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 1 | 1 | 2 |
2006 | 0 | 1 | 1 |
2007 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2013 | 1 | 0 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vaccines, Subunit" by people in Profiles.
-
Evaluation of a subunit vaccine candidate (Biotech Vac Cox) against Eimeria spp. in broiler chickens. Poult Sci. 2021 Sep; 100(9):101329.
-
Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial. Vaccine. 2016 Jan 12; 34(3):313-9.
-
Carrier protein influences immunodominance of a known epitope: implication in peptide vaccine design. Vaccine. 2013 Sep 23; 31(41):4682-8.
-
Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines. Vaccine. 2009 May 14; 27(22):2981-8.
-
Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells. J Immunother. 2007 Jan; 30(1):40-53.
-
Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants. Infect Immun. 2007 Feb; 75(2):621-33.
-
Lack of induction of autoantibody responses following immunization with cytomegalovirus (CMV) glycoprotein B (gB) in healthy CMV-seronegative subjects. Vaccine. 2004 Dec 16; 23(5):687-92.
-
Paracrine release of IL-12 stimulates IFN-gamma production and dramatically enhances the antigen-specific T cell response after vaccination with a novel peptide-based cancer vaccine. J Immunol. 2004 May 01; 172(9):5159-67.